共 50 条
The prognostic role of markers of systemic inflammation in patients with metastatic lung cancer receiving immunotherapy: A comprehensive review of the literature
被引:0
作者:
Zlatanova, Tanya
[1
]
Arabadjiev, Jeliazko
[1
]
机构:
[1] Acibadem City Clin UMHAT Tokuda, Sofia, Bulgaria
来源:
关键词:
markers of systemic inflammation;
lung cancer;
immunotherapy;
LYMPHOCYTE RATIO PREDICTS;
NEUTROPHIL;
INDEX;
SURVIVAL;
PLATELET;
D O I:
10.3897/pharmacia.71.e115558
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Lung carcinoma stands as a prevalent malignancy characterized by a distressingly elevated fatality rate. Immunotherapy, administered either as a monotherapy or together with chemotherapy, represents the primary therapeutic approach for the majority of individuals grappling with advanced non-small cell lung cancer. The influence of systemic inflammation in fostering cancer dissemination and progression is a well-documented phenomenon. This literature review examines contemporary indices and scoring systems, which have emerged as informative indicators of systemic inflammation in recent years. These indices and scores are valuable prognostic and predictive elements in assessing treatment response among patients with metastatic lung cancer undergoing immunotherapeutic treatment.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条